Description

[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate is a high-purity, structured lipid compound of significant interest in advanced biochemical research and pharmaceutical development. This molecule is critical for studies involving lipid metabolism, cellular signaling, and the formulation of specialized drug delivery systems. It is primarily sought by research institutions and pharmaceutical companies engaged in developing novel therapeutics and high-value nutraceuticals.

Application

• Pharmaceutical Intermediate: Serves as a key building block in the synthesis of specialized sterol and lipid-based active pharmaceutical ingredients (APIs).
• Biochemical Research: Used as a reference standard and substrate in studies of lipidomics, enzyme kinetics, and metabolic pathways.
• Drug Delivery Systems: Incorporated into liposomal and nanoparticle formulations to enhance drug solubility, stability, and targeted delivery.
• Nutraceutical Development: A potential component in the research and development of advanced dietary supplements targeting specific health functions.
• Cell Culture & Media: May be used as a specialized component in cell culture media for demanding research applications.
• Analytical Standard: Provides a high-purity standard for quality control and method development in analytical laboratories (HPLC, GC-MS).

Basic Information

Product Name	[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
CAS No.	70110-50-8
Molecular Formula	C49H74O2
Molecular Weight	711.1 g/mol
Synonyms	Cholesteryl Docosahexaenoate; Cholesteryl DHA; Cholesterol DHA Ester; 22:6(n-3) Cholesteryl Ester; Cholesteryl (all-Z)-4,7,10,13,16,19-docosahexaenoate; DHA-Cholesterol Ester; 5-Cholesten-3β-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
EINECS	Contact for details

Quality Control

Our [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency. Certificates of Analysis (COA) detailing specific results for purity, related substances, and other critical parameters are provided with every shipment to support your research and regulatory needs.

Storage

Preserve in a tightly closed container, protected from light. For long-term storage, keep the sealed container under an inert atmosphere (e.g., nitrogen or argon) at -20°C or below to minimize oxidation and degradation. Allow the product to equilibrate to room temperature in a desiccator before opening to prevent moisture condensation.

Specification

Item	Specification
Appearance	White to off-white solid or viscous oil
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Solvent Residues (GC)	Meets ICH guidelines
Heavy Metals	< 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.